publication date: Dec. 18, 2010

In this issue: 

FDA Urges Lower Target for ESA Use; Market Could Drop By More Than Half.

CMS Launches National Coverage Analysis, Citing FDA’s Black Box Warning on ESAs.

FDA Purges Quality of Life Claims from Oncology Label for ESAs.

Amgen Says It Can Demonstrate Safety of Existing Hg Target.

If You Were On ODAC: Experts Suggest Questions For May 10 Advisory Meeting.

Download (PDF 1.1MB)

To access this members-only content, please log in.
Institutional subscribers, please log in with your IP.
If you're not a subscriber why not join today?
To gain access to the members only content click here to subscribe.
You will be given immediate access to premium content on the site.
Click here to join.

Copyright (c) 2020 The Cancer Letter Inc.